Cytomx Therapeutics, Inc.

CytomX Therapeutics, Inc. is a biopharmaceutical company specializing in the development of innovative antibody therapeutics. With a focus on Probody therapeutics, CytomX is leveraging its proprietary platform to create novel, potentially more effective treatments for cancer and other serious diseases. Probody therapeutics are designed to selectively target tumor cells while sparing healthy tissue, aiming to improve the therapeutic index of drugs and reduce side effects. CytomX is committed to advancing the field of precision medicine and improving patient outcomes through its groundbreaking research and development efforts.